Ignite Creation Date:
2024-05-05 @ 6:48 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00542971
Status:
COMPLETED
Last Update Posted:
2018-08-23
First Post:
2007-10-10
Brief Title:
Phase I-II Study of Idarubicin Cytarabine and Sorafenib BAY43-9006
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Disorders |
| AML |
| Acute Myeloid Leukemia |